XML 14 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2019
Sep. 30, 2018
ASSETS    
Cash and cash equivalents $ 274.4 $ 342.3
Cash, securities and other assets segregated under federal and other regulations (including $235.8 and $643.3 at fair value at March 31, 2019 and September 30, 2018, respectively) 959.0 1,408.7
Collateralized transactions:    
Securities purchased under agreements to resell 1,242.4 870.8
Securities borrowed 1,289.8 225.5
Deposits with and receivables from broker-dealers, clearing organizations and counterparties, net (including $422.7 and $517.4 at fair value at March 31, 2019 and September 30, 2018, respectively) 2,266.8 2,234.5
Receivables from customers, net 305.3 288.0
Notes receivable 2.6 3.8
Income taxes receivable 0.3 0.3
Financial instruments owned, at fair value (includes securities pledged as collateral that can be sold or repledged of $285.5 and $123 at March 31, 2019 and September 30, 2018, respectively) 2,596.7 2,054.8
Physical commodities inventory, net (including $202.9 and $156.9 at fair value at March 31, 2019 and September 30, 2018, respectively) 279.8 222.5
Deferred income taxes, net 22.8 19.8
Property and equipment, net 45.6 42.4
Goodwill and intangible assets, net 59.4 59.8
Other assets 62.8 51.5
Total assets 9,407.7 7,824.7
Liabilities:    
Accounts payable and other accrued liabilities 128.3 145.4
Payables to:    
Customers 2,994.6 3,639.6
Broker-dealers, clearing organizations and counterparties (including $15.8 and $0 at fair value at March 31, 2019 and September 30, 2018), respectively 575.2 89.5
Debt, Long-term and Short-term, Combined Amount 256.8 355.2
Senior secured term loan, net 171.8 0.0
Income taxes payable 11.3 8.6
Collateralized transactions:    
Securities sold under agreements to repurchase 2,384.7 1,936.7
Securities loaned 1,376.5 277.9
Financial instruments sold, not yet purchased, at fair value 956.7 866.5
Total liabilities 8,855.9 7,319.4
Stockholders' Equity:    
Preferred stock, $0.01 par value. Authorized 1,000,000 shares; no shares issued or outstanding 0.0 0.0
Common stock, $0.01 par value. Authorized 30,000,000 shares; 21,154,065 issued and 19,032,108 outstanding at March 31, 2019 and 21,030,497 issued and 18,908,540 outstanding at September 30, 2018 0.2 0.2
Common stock in treasury, at cost - 2,121,957 shares at March 31, 2019 and September 30, 2018 (46.3) (46.3)
Additional paid-in capital 272.1 267.5
Retained earnings 358.6 317.0
Accumulated other comprehensive loss, net (32.8) (33.1)
Total stockholders' equity 551.8 505.3
Total liabilities and stockholders' equity $ 9,407.7 $ 7,824.7